Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors
Clare J. Stones(University of Auckland), Bruce C. Baguley(Maurice Wilkins Centre)
Cited by 43
Related Papers
Evidence for the Existence of Triple-Negative Variants in the MCF-7 Breast Cancer Cell Population
|BioMed Research International|2014|46
Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines
|PLoS ONE|2015|45
MITF and PAX3 Play Distinct Roles in Melanoma Cell Migration; Outline of a “Genetic Switch” Theory Involving MITF and PAX3 in Proliferative and Invasive Phenotypes of Melanoma
|Frontiers in Oncology|2013|38
Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers
|Frontiers in Oncology|2017|33